EYE VITAMINS BY BAUSCH + LOMB: Bausch + Lomb carries a full line of ocular supplements with vitamins, minerals & nutrients that include Lutein & Zeaxanthin that promote eye health, including ...

Dog owners often use wipes to keep their pets’ eyes clean and healthy. But Bausch + Lomb is recalling 32,000 units is its Project Watson Eyelid Wipes for Dogs because they can pose a threat to ...

A recall was issued for Bausch + Lomb's Project Watson dog eyelid wipes because of the risk that fungi and bacteria can begin to grow in the containers, posing a risk of infection for pets ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United ...

Michael K. Jensen, B.S.Pharm., M.S., is Clinical Associate Professor of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City, and Clinical ...

VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2024 ...

Good morning, and welcome to the Bausch + Lomb's First Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ...

This was led by its foundational Bausch + Lomb unit; it saw an 11% increase, matching that of total revenue. Bausch also reaffirmed its guidance for full-year 2024. It stated again that it's ...

Amelia Ti is a Registered Dietitian (RD) and Certified Diabetes Care and Education Specialist (CDCES) based in NYC. She completed her Bachelor's in Nutrition & Dietetics at NYU and Master's in ...

On Monday, Bausch & Lomb Corp. (NYSE:BLCO) received an upgrade in stock rating from Morgan Stanley, moving from Equal-weight to Overweight. Accompanying this upgrade, the firm also raised the ...

Both were evaluated on postoperative infection rates (clinical outcomes) and their cost to our setting, including their use in all cases involving eye surgery (i.e., cataract, corneal, retinal ...